Revolver Therapeutics

Revolver Therapeutics develops peptide therapeutics using a screening platform to target transcription factors for cancer treatment.

Voice and audio AIHealth and bioManufacturing and industrial

Revolver Therapeutics has no funding amount on record yet; its latest known round is Pre Seed (Jul 2026). Recent Funding first saw it on October 2, 2026.

Raise history

1. July 3, 2026
   Pre Seed · amount undisclosed
   Source: crunchbase.com

Related bio health companies

• MM-BasedOct 1, 2026
• AAyna HealthOct 1, 2026
• VVytalYou$830K · Sep 30, 2026
• LLindera USSep 29, 2026
• OOrtet$500M · Sep 29, 2026
• AAptadir Therapeutics$45M · Sep 29, 2026
• GGoerSep 29, 2026
• FFreyyaSep 29, 2026

Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/revolver-therapeutics.